Department of Biological Sciences, Electron Microscopy Center, State University of Santa Cruz, Ilheus, Brazil.
Department of Agricultural and Environmental Sciences, Animal Reproduction Laboratory, State University of Santa Cruz, Ilheus, Brazil.
Reprod Domest Anim. 2024 Jun;59(6):e14630. doi: 10.1111/rda.14630.
This study evaluated whether the treatment of pseudopregnancy in bitches with vitamin B6 modulates uterine expression of receptors for progesterone (PR), oestrogen (ERα), androgen (AR), thyroid hormone (TRα) and the kisspeptin/Kiss1r system. Eighteen pseudopregnant bitches were treated for 20 days in groups receiving placebo (n = 6); cabergoline (5 μg/kg/day; n = 6); or vitamin B6 (50 mg/kg/day; n = 6). Blood was collected on the 1st day of drug administration and 120 h later to measure serum prolactin (PRL). After treatment, they were ovariohysterectomized and uterine fragments were collected for histomorphometry and immunohistochemical evaluation of PR, ERα, AR, TRα, Kiss1 and Kiss1r. After 120 h of cabergoline or vitamin B6 treatment, PRL levels were reduced in the bitches, confirming the antiprolactinemic effect of these drugs. Furthermore, regardless of treatment, the animals exhibited uterine histomorphometry consistent with dioestrus. The PR showed strong immunostaining in all regions and an increase in scores was observed for this receptor in animals treated with vitamin B6 in deep glands. In contrast, ERα and Kiss1R receptors showed weak to no immunostaining in all uterine regions and no changes between groups. Regarding AR, most animals treated with vitamin B6 showed increased trends in the deep gland and myometrium marking scores. In contrast, in both vitamin B6 and cabergoline treatments, a reduction in TRα marking scores was observed compared to the control group. In addition, on the endometrial surface, a reduction was observed in the marked area of Kiss1 after administration of cabergoline when compared to the pseudopregnant control group. These findings shed valuable insight into the use of vitamin B6 as a drug with actions similar to cabergoline in reducing PRL and uterine modulation in bitches.
本研究评估了维生素 B6 治疗犬假性妊娠是否调节孕激素(PR)、雌激素(ERα)、雄激素(AR)、甲状腺激素(TRα)和 kisspeptin/Kiss1r 系统的受体在子宫中的表达。18 只假性妊娠犬被分为三组,分别接受安慰剂(n=6)、卡麦角林(5μg/kg/天;n=6)或维生素 B6(50mg/kg/天;n=6)治疗 20 天。在药物给药的第 1 天和 120 小时后采集血液,以测量血清催乳素(PRL)。治疗后,对犬进行卵巢子宫切除术,并采集子宫片段进行组织形态计量学和 PR、ERα、AR、TRα、Kiss1 和 Kiss1r 的免疫组织化学评估。卡麦角林或维生素 B6 治疗 120 小时后,犬的 PRL 水平降低,证实了这些药物的抗催乳素作用。此外,无论治疗如何,动物的子宫组织形态计量学都与发情期一致。PR 在所有区域均表现出强烈的免疫染色,并且在维生素 B6 治疗的动物的深腺中观察到该受体的评分增加。相比之下,ERα 和 Kiss1R 受体在所有子宫区域均表现出弱至无免疫染色,各组之间没有变化。关于 AR,大多数接受维生素 B6 治疗的动物在深腺和子宫肌层标记评分中表现出增加的趋势。相比之下,在维生素 B6 和卡麦角林治疗中,与对照组相比,TRα 标记评分降低。此外,与假性妊娠对照组相比,卡麦角林给药后,在子宫内膜表面,Kiss1 的标记区域减少。这些发现为维生素 B6 作为一种具有与卡麦角林类似作用的药物,用于降低犬的 PRL 和子宫调节提供了有价值的见解。